This information could help providers personalize breast cancer screening strategies and initiate treatment earlier.

After reviewing years of data from its clinic, one institution discovered that issues with implant data integrity frequently put patients at risk. 

According to new survey data, nonadherence is not for lack of concern about the disease—75% of the women surveyed reported being concerned about their breast health.  

This week, the American Cancer Society’s annual Breast Cancer Statistics report revealed several eye-opening figures.

It allows providers to quantify changes in tumor size throughout patients’ treatment in real-time, providing early indications of efficacy and enabling adjustments as needed.

New research suggests that treatment regimens can be nearly halved without increasing the risk of recurrence or complications further down the road. 

Experts are calling the agent “the most exciting development in the field of nuclear cardiology" in several decades.

Currently, there is no standardized reporting requirement related to BACs, and ACR classifies reporting vascular calcifications on breast imaging as optional.